Norbrook Laboratories (Feline Hyperthyroidism Drug) Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Norbrook Laboratories (Feline Hyperthyroidism Drug) General Information

Description

A Feline Hyperthyroidism Drug.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Newry
  • Northern Ireland, United Kingdom
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • Newry
  • Northern Ireland, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Norbrook Laboratories (Feline Hyperthyroidism Drug) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Norbrook Laboratories (Feline Hyperthyroidism Drug)‘s full profile, request access.

Request a free trial

Norbrook Laboratories (Feline Hyperthyroidism Drug) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Norbrook Laboratories (Feline Hyperthyroidism Drug)‘s full profile, request access.

Request a free trial

Norbrook Laboratories (Feline Hyperthyroidism Drug) FAQs

  • When was Norbrook Laboratories (Feline Hyperthyroidism Drug) founded?

    Norbrook Laboratories (Feline Hyperthyroidism Drug) was founded in 2016.

  • Where is Norbrook Laboratories (Feline Hyperthyroidism Drug) headquartered?

    Norbrook Laboratories (Feline Hyperthyroidism Drug) is headquartered in Newry, United Kingdom.

  • What industry is Norbrook Laboratories (Feline Hyperthyroidism Drug) in?

    Norbrook Laboratories (Feline Hyperthyroidism Drug)’s primary industry is Buildings and Property.

  • Is Norbrook Laboratories (Feline Hyperthyroidism Drug) a private or public company?

    Norbrook Laboratories (Feline Hyperthyroidism Drug) is a Private company.

  • What is the current valuation of Norbrook Laboratories (Feline Hyperthyroidism Drug)?

    The current valuation of Norbrook Laboratories (Feline Hyperthyroidism Drug) is .

  • What is Norbrook Laboratories (Feline Hyperthyroidism Drug)’s current revenue?

    The current revenue for Norbrook Laboratories (Feline Hyperthyroidism Drug) is .

  • Who are Norbrook Laboratories (Feline Hyperthyroidism Drug)’s investors?

    Norbrook Laboratories has invested in Norbrook Laboratories (Feline Hyperthyroidism Drug).

  • When was Norbrook Laboratories (Feline Hyperthyroidism Drug) acquired?

    Norbrook Laboratories (Feline Hyperthyroidism Drug) was acquired on 16-Dec-2025.

  • Who acquired Norbrook Laboratories (Feline Hyperthyroidism Drug)?

    Norbrook Laboratories (Feline Hyperthyroidism Drug) was acquired by Virbac.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process